Dysregulation of MicroRNAs in cancer

Journal of Biomedical Science

Volumn 19, Issue 1, 2012, Pages

  Chen, Pai Sheng ^a,d   Su, Jen Liang ^b,c,d   Hung, Mien Chie ^d,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c ASIA UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Cancer progression; miRNA biogenesis; miRNA dysregulation

Indexed keywords

DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; MICRORNA; MICRORNA 10B; MICRORNA 155; MICRORNA 15A; MICRORNA 16; MICRORNA 17 3P; MICRORNA 17 5P; MICRORNA 18A; MICRORNA 19A; MICRORNA 20A; MICRORNA 29B; MICRORNA 34A; MICRORNA 375; MICRORNA 451; MICRORNA 520; MICRORNA 98; MICRORNA LET 7 A 1; MICRORNA LET 7 A 2; MICRORNA LET 7 A 3; MICRORNA LET 7 B; MICRORNA LET 7 C; MICRORNA LET 7 D; MICRORNA LET 7 E; MICRORNA LET 7 F 1; MICRORNA LET 7 F 2; MICRORNA LET 7 G; MICRORNA LET 7 I; UNCLASSIFIED DRUG; UNINDEXED DRUG;

3' UNTRANSLATED REGION; APOPTOSIS; BIOGENESIS; CANCER CELL; CANCER GROWTH; CANCER RESISTANCE; CELL CYCLE ARREST; CELL MATURATION; CHROMOSOME 13Q; CHRONIC LYMPHATIC LEUKEMIA; CPG ISLAND; DISEASE COURSE; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DRUG RESISTANCE; EPITHELIAL MESENCHYMAL TRANSITION; GENE DELETION; HIGH THROUGHPUT SEQUENCING; HISTONE MODIFICATION; HUMAN; LUNG CANCER; MELANOMA; METASTASIS; NEOPLASM; NONHUMAN; ONCOGENE; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; REVIEW; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SCREENING; METABOLISM;

DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASMS; ONCOGENES;

EID: 84867441742     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-19-90     Document Type: Review

References (75)

1. MicroRNA expression profiles classify human cancers. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR, Nature 2005 435 7043 834 838 10.1038/nature03702 15944708 (Pubitemid 40839735)
2. MicroRNA signatures in human cancers. Calin GA, Croce CM, Nat Rev Cancer 2006 6 11 857 866 10.1038/nrc1997 17060945 (Pubitemid 44629897)
3. MicroRNA signature predicts survival and relapse in lung cancer. Yu SL, Chen HY, Chang GC, Chen CY, Chen HW, Singh S, Cheng CL, Yu CJ, Lee YC, Chen HS, Su TJ, Chiang CC, Li HN, Hong QS, Su HY, Chen CC, Chen WJ, Liu CC, Chan WK, Li KC, Chen JJ, Yang PC, Cancer Cell 2008 13 1 48 57 10.1016/j.ccr.2007.12.008 18167339 (Pubitemid 350309743)
4. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM, N Engl J Med 2005 353 17 1793 1801 10.1056/NEJMoa050995 16251535 (Pubitemid 41549891)
5. MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. Bloomston M, Frankel WL, Petrocca F, Volinia S, Alder H, Hagan JP, Liu CG, Bhatt D, Taccioli C, Croce CM, Jama 2007 297 17 1901 1908 10.1001/jama.297.17.1901 17473300 (Pubitemid 46707844)
6. RAS is regulated by the let-7 microRNA family. Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ, Cell 2005 120 5 635 647 10.1016/j.cell.2005.01.014 15766527 (Pubitemid 40343076)
7. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T, Proc Natl Acad Sci U S A 2008 105 10 3903 3908 10.1073/pnas.0712321105 18308936 (Pubitemid 351723497)
8. MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth. Nadiminty N, Tummala R, Lou W, Zhu Y, Shi XB, Zou JX, Chen H, Zhang J, Chen X, Luo J, Devere White RW, Kung HJ, Evans CP, Gao AC, PLoS One 2012 7 3 32832 10.1371/journal.pone.0032832 22479342
9. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Mayr C, Hemann MT, Bartel DP, Science 2007 315 5818 1576 1579 10.1126/science.1137999 17322030 (Pubitemid 46449474)
10. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Lee YS, Dutta A, Genes Dev 2007 21 9 1025 1030 10.1101/gad.1540407 17437991 (Pubitemid 46686471)
11. MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7. Kim SJ, Shin JY, Lee KD, Bae YK, Sung KW, Nam SJ, Chun KH, Breast Cancer Res 2012 14 1 14 10.1186/bcr3098 22251626
12. MicroRNA let-7f inhibits tumor invasion and metastasis by targeting MYH9 in human gastric cancer. Liang S, He L, Zhao X, Miao Y, Gu Y, Guo C, Xue Z, Dou W, Hu F, Wu K, Nie Y, Fan D, PLoS One 2011 6 4 18409 10.1371/journal.pone. 0018409 21533124
13. miR-19 is a key oncogenic component of mir-17-92. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L, Genes Dev 2009 23 24 2839 2849 10.1101/gad.1861409 20008935
14. A microRNA polycistron as a potential human oncogene. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM, Nature 2005 435 7043 828 833 10.1038/nature03552 15944707 (Pubitemid 40839734)
15. The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Hong L, Lai M, Chen M, Xie C, Liao R, Kang YJ, Xiao C, Hu WY, Han J, Sun P, Cancer Res 2010 70 21 8547 8557 10.1158/0008-5472.CAN- 10-1938 20851997
16. "Myc'ed messages": myc induces transcription of E2F1 while inhibiting its translation via a microRNA polycistron. Coller HA, Forman JJ, Legesse-Miller A, PLoS Genet 2007 3 8 146 10.1371/journal.pgen.0030146 17784791 (Pubitemid 47358072)
17. Mir-17-5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Hossain A, Kuo MT, Saunders GF, Mol Cell Biol 2006 26 21 8191 8201 10.1128/MCB.00242-06 16940181 (Pubitemid 44631015)
18. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Chan JA, Krichevsky AM, Kosik KS, Cancer Res 2005 65 14 6029 6033 10.1158/0008-5472.CAN-05-0137 16024602 (Pubitemid 40994386)
19. MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas. Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K, Cancer Res 2007 67 19 8994 9000 10.1158/0008-5472.CAN-07-1045 17908999 (Pubitemid 47535880)
20. MicroRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells. Papagiannakopoulos T, Shapiro A, Kosik KS, Cancer Res 2008 68 19 8164 8172 10.1158/0008-5472.CAN-08-1305 18829576
21. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH, J Biol Chem 2008 283 2 1026 1033 10.1074/jbc.M707224200 17991735
22. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Yao Q, Xu H, Zhang QQ, Zhou H, Qu LH, Biochem Biophys Res Commun 2009 388 3 539 542 10.1016/j.bbrc.2009.08.044 19682430
23. Micromanagers of malignancy: role of microRNAs in regulating metastasis. Ma L, Weinberg RA, Trends Genet 2008 24 9 448 456 10.1016/j.tig.2008.06.004 18674843
24. MicroRNAs-the micro steering wheel of tumour metastases. Nicoloso MS, Spizzo R, Shimizu M, Rossi S, Calin GA, Nat Rev Cancer 2009 9 4 293 302 10.1038/nrc2619 19262572
25. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Ma L, Teruya-Feldstein J, Weinberg RA, Nature 2007 449 7163 682 688 10.1038/nature06174 17898713 (Pubitemid 47552092)
26. Endogenous human microRNAs that suppress breast cancer metastasis. Tavazoie SF, Alarcon C, Oskarsson T, Padua D, Wang Q, Bos PD, Gerald WL, Massague J, Nature 2008 451 7175 147 152 10.1038/nature06487 18185580
27. The epithelial-mesenchymal transition generates cells with properties of stem cells. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, Campbell LL, Polyak K, Brisken C, Yang J, Weinberg RA, Cell 2008 133 4 704 715 10.1016/j.cell.2008.03.027 18485877 (Pubitemid 351636299)
28. p53 regulates epithelial-mesenchymal transition and stem cell properties through modulating miRNAs. Chang CJ, Chao CH, Xia W, Yang JY, Xiong Y, Li CW, Yu WH, Rehman SK, Hsu JL, Lee HH, Liu M, Chen CT, Yu D, Hung MC, Nat Cell Biol 2011 13 3 317 323 10.1038/ncb2173 21336307
29. MicroRNA-335 acts as a metastasis suppressor in gastric cancer by targeting Bcl-w and specificity protein 1. Xu Y, et al. Oncogene 2011 31 11 1398 407 21822301
30. MiRNA-335 Suppresses Neuroblastoma Cell Invasiveness By Direct Targeting of Multiple Genes from the non-Canonical TGF-beta Signalling Pathway. Lynch J, et al. Carcinogenesis 2012 33 5 976 85 10.1093/carcin/bgs114 22382496
31. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Huang Q, Gumireddy K, Schrier M, le Sage C, Nagel R, Nair S, Egan DA, Li A, Huang G, Klein-Szanto AJ, Gimotty PA, Katsaros D, Coukos G, Zhang L, Pure E, Agami R, Nat Cell Biol 2008 10 2 202 210 10.1038/ncb1681 18193036 (Pubitemid 351194050)
32. A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. Voorhoeve PM, le Sage C, Schrier M, Gillis AJ, Stoop H, Nagel R, Liu YP, van Duijse J, Drost J, Griekspoor A, Zlotorynski E, Yabuta N, De Vita G, Nojima H, Looijenga LH, Agami R, Cell 2006 124 6 1169 1181 10.1016/j.cell.2006.02.037 16564011
33. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D, PLoS Genet 2010 6 3 1000879 10.1371/journal.pgen.1000879 20300657
34. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. Ding Q, Chang CJ, Xie X, Xia W, Yang JY, Wang SC, Wang Y, Xia J, Chen L, Cai C, Li H, Yen CJ, Kuo HP, Lee DF, Lang J, Huo L, Cheng X, Chen YJ, Li CW, Jeng LB, Hsu JL, Li LY, Tan A, Curley SA, Ellis LM, Dubois RN, Hung MC, The Journal of clinical investigation 2011 121 11 4526 4536 10.1172/JCI45008 21985787
35. Escape from hsa-miR-519c enables drug-resistant cells to maintain high expression of ABCG2. To KK, Robey RW, Knutsen T, Zhan Z, Ried T, Bates SE, Mol Cancer Ther 2009 8 10 2959 2968 10.1158/1535-7163.MCT-09-0292 19825807
36. MicroRNA-519c suppresses hypoxia-inducible factor-1alpha expression and tumor angiogenesis. Cha ST, Chen PS, Johansson G, Chu CY, Wang MY, Jeng YM, Yu SL, Chen JS, Chang KJ, Jee SH, Tan CT, Lin MT, Kuo ML, Cancer Res 2010 70 7 2675 2685 10.1158/0008-5472.CAN-09-2448 20233879
37. Downregulation of microRNA miR-520h by E1A contributes to anticancer activity. Su JL, Chen PB, Chen YH, Chen SC, Chang YW, Jan YH, Cheng X, Hsiao M, Hung MC, Cancer Res 2010 70 12 5096 5108 10.1158/0008-5472.CAN-09-4148 20501832
38. MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol. Yu YH, et al. Oncogene 2012 [Epub ahead of print] 10.1038/onc.2012.74
39. miR-15 and miR-16 induce apoptosis by targeting BCL2. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM, Proc Natl Acad Sci U S A 2005 102 39 13944 13949 10.1073/pnas.0506654102 16166262 (Pubitemid 41377683)
40. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Xia L, Zhang D, Du R, Pan Y, Zhao L, Sun S, Hong L, Liu J, Fan D, Int J Cancer 2008 123 2 372 379 10.1002/ijc.23501 18449891 (Pubitemid 351842022)
41. Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin. Kovalchuk O, Filkowski J, Meservy J, Ilnytskyy Y, Tryndyak VP, Chekhun VF, Pogribny IP, Mol Cancer Ther 2008 7 7 2152 2159 10.1158/1535-7163.MCT-08-0021 18645025
42. Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, Yang JM, Biochem Pharmacol 2008 76 5 582 588 10.1016/j.bcp.2008.06.007 18619946
43. miR-21-mediated tumor growth. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY, Oncogene 2007 26 19 2799 2803 10.1038/sj.onc.1210083 17072344 (Pubitemid 46663837)
44. mir-29 regulates Mcl-1 protein expression and apoptosis. Mott JL, Kobayashi S, Bronk SF, Gores GJ, Oncogene 2007 26 42 6133 6140 10.1038/sj.onc.1210436 17404574 (Pubitemid 47414372)
45. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E, Schwind S, Pang J, Yu J, Muthusamy N, Havelange V, Volinia S, Blum W, Rush LJ, Perrotti D, Andreeff M, Bloomfield CD, Byrd JC, Chan K, Wu LC, Croce CM, Marcucci G, Blood 2009 113 25 6411 6418 10.1182/blood-2008-07-170589 19211935
46. MicroRNA 29c is down-regulated in nasopharyngeal carcinomas, up-regulating mRNAs encoding extracellular matrix proteins. Sengupta S, den Boon JA, Chen IH, Newton MA, Stanhope SA, Cheng YJ, Chen CJ, Hildesheim A, Sugden B, Ahlquist P, Proc Natl Acad Sci U S A 2008 105 15 5874 5878 10.1073/pnas. 0801130105 18390668 (Pubitemid 351758465)
47. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, Shimizu M, Rattan S, Bullrich F, Negrini M, Croce CM, Proc Natl Acad Sci U S A 2004 101 9 2999 3004 10.1073/pnas.0307323101 14973191 (Pubitemid 38327724)
48. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM, Proc Natl Acad Sci U S A 2002 99 24 15524 15529 10.1073/pnas.242606799 12434020 (Pubitemid 35403967)
49. microRNAs exhibit high frequency genomic alterations in human cancer. Zhang L, Huang J, Yang N, Greshock J, Megraw MS, Giannakakis A, Liang S, Naylor TL, Barchetti A, Ward MR, Yao G, Medina A, O'Brien-Jenkins A, Katsaros D, Hatzigeorgiou A, Gimotty PA, Weber BL, Coukos G, Proc Natl Acad Sci U S A 2006 103 24 9136 9141 10.1073/pnas.0508889103 16754881 (Pubitemid 43902545)
50. High expression of precursor microRNA-155/BIC RNA in children with Burkitt lymphoma. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A, Genes Chromosomes Cancer 2004 39 2 167 169 10.1002/gcc.10316 14695998 (Pubitemid 38056091)
51. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, Jones PA, Cancer Cell 2006 9 6 435 443 10.1016/j.ccr.2006.04.020 16766263 (Pubitemid 43832188)
52. Genetic unmasking of an epigenetically silenced microRNA in human cancer cells. Lujambio A, Ropero S, Ballestar E, Fraga MF, Cerrato C, Setien F, Casado S, Suarez-Gauthier A, Sanchez-Cespedes M, Git A, Spiteri I, Das PP, Caldas C, Miska E, Esteller M, Cancer Res 2007 67 4 1424 1429 10.1158/0008-5472.CAN-06- 4218 17308079 (Pubitemid 46383366)
53. Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis. Lu L, Katsaros D, de la Longrais IA, Sochirca O, Yu H, Cancer Res 2007 67 21 10117 10122 10.1158/0008-5472.CAN-07-2544 17974952 (Pubitemid 350070782)
54. Epigenetic regulation of microRNA-375 and its role in melanoma development in humans. Mazar J, DeBlasio D, Govindarajan SS, Zhang S, Perera RJ, FEBS Lett 2011 585 15 2467 2476 10.1016/j.febslet.2011.06.025 21723283
55. A microRNA component of the p53 tumour suppressor network. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, Xue W, Zender L, Magnus J, Ridzon D, Jackson AL, Linsley PS, Chen C, Lowe SW, Cleary MA, Hannon GJ, Nature 2007 447 7148 1130 1134 10.1038/nature05939 17554337 (Pubitemid 47014436)
56. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, Oren M, Mol Cell 2007 26 5 731 743 10.1016/j.molcel. 2007.05.017 17540598 (Pubitemid 46856247)
57. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, Mendell JT, Mol Cell 2007 26 5 745 752 10.1016/j.molcel.2007.05.010 17540599 (Pubitemid 46856245)
58. c-Myc-regulated microRNAs modulate E2F1 expression. O'Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT, Nature 2005 435 7043 839 843 10.1038/nature03677 15944709 (Pubitemid 40839736)
59. Widespread microRNA repression by Myc contributes to tumorigenesis. Chang TC, Yu D, Lee YS, Wentzel EA, Arking DE, West KM, Dang CV, Thomas-Tikhonenko A, Mendell JT, Nat Genet 2008 40 1 43 50 10.1038/ng.2007.30 18066065
60. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A, Cancer Cell 2008 13 3 272 286 10.1016/j.ccr.2008.02.013 18328430 (Pubitemid 351318375)
61. Lin28 promotes transformation and is associated with advanced human malignancies. Viswanathan SR, Powers JT, Einhorn W, Hoshida Y, Ng TL, Toffanin S, O'Sullivan M, Lu J, Phillips LA, Lockhart VL, Shah SP, Tanwar PS, Mermel CH, Beroukhim R, Azam M, Teixeira J, Meyerson M, Hughes TP, Llovet JM, Radich J, Mullighan CG, Golub TR, Sorensen PH, Daley GQ, Nat Genet 2009 41 7 843 848 10.1038/ng.392 19483683
62. A LIN28-dependent structural change in pre-let-7g directly inhibits dicer processing. Lightfoot HL, Bugaut A, Armisen J, Lehrbach NJ, Miska EA, Balasubramanian S, Biochemistry 2011 50 35 7514 7521 10.1021/bi200851d 21815640
63. Lin28 recruits the TUTase Zcchc11 to inhibit let-7 maturation in mouse embryonic stem cells. Hagan JP, Piskounova E, Gregory RI, Nat Struct Mol Biol 2009 16 10 1021 1025 10.1038/nsmb.1676 19713958
64. Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Piskounova E, Polytarchou C, Thornton JE, LaPierre RJ, Pothoulakis C, Hagan JP, Iliopoulos D, Gregory RI, Cell 2011 147 5 1066 1079 10.1016/j.cell.2011.10.039 22118463
65. The RNA-binding protein KSRP promotes the biogenesis of a subset of microRNAs. Trabucchi M, Briata P, Garcia-Mayoral M, Haase AD, Filipowicz W, Ramos A, Gherzi R, Rosenfeld MG, Nature 2009 459 7249 1010 1014 10.1038/nature08025 19458619
66. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Guil S, Caceres JF, Nat Struct Mol Biol 2007 14 7 591 596 10.1038/nsmb1250 17558416 (Pubitemid 47037061)
67. Posttranscriptional regulation of miRNAs harboring conserved terminal loops. Michlewski G, Guil S, Semple CA, Caceres JF, Mol Cell 2008 32 3 383 393 10.1016/j.molcel.2008.10.013 18995836
68. Antagonistic role of hnRNP A1 and KSRP in the regulation of let-7a biogenesis. Michlewski G, Caceres JF, Nat Struct Mol Biol 2010 17 8 1011 1018 10.1038/nsmb.1874 20639884
69. Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins. Shiohama A, Sasaki T, Noda S, Minoshima S, Shimizu N, Exp Cell Res 2007 313 20 4196 4207 10.1016/j.yexcr.2007.07.020 17765891 (Pubitemid 350087044)
70. SMAD proteins control DROSHA-mediated microRNA maturation. Davis BN, Hilyard AC, Lagna G, Hata A, Nature 2008 454 7200 56 61 10.1038/nature07086 18548003 (Pubitemid 351931982)
71. Modulation of microRNA processing by p53. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K, Nature 2009 460 7254 529 533 10.1038/nature08199 19626115
72. Maturation of microRNA is hormonally regulated by a nuclear receptor. Yamagata K, Fujiyama S, Ito S, Ueda T, Murata T, Naitou M, Takeyama K, Minami Y, O'Malley BW, Kato S, Mol Cell 2009 36 2 340 347 10.1016/j.molcel.2009.08.017 19854141
73. BRCA1 regulates microRNA biogenesis via the DROSHA microprocessor complex. Kawai S, Amano A, J Cell Biol 2012 197 2 201 208 10.1083/jcb.201110008 22492723
74. miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans. Chen PS, Su JL, Cha ST, Tarn WY, Wang MY, Hsu HC, Lin MT, Chu CY, Hua KT, Chen CN, Kuo TC, Chang KJ, Hsiao M, Chang YW, Chen JS, Yang PC, Kuo ML, J Clin Invest 2011 121 9 3442 3455 10.1172/JCI45390 21841313
75. Mouse miRNA-709 directly regulates miRNA-15a/16-1 biogenesis at the posttranscriptional level in the nucleus: evidence for a microRNA hierarchy system. Tang R, Li L, Zhu D, Hou D, Cao T, Gu H, Zhang J, Chen J, Zhang CY, Zen K, Cell Res 2012 22 3 504 515 10.1038/cr.2011.137 21862971